GSK ties up with iTeos to develop cancer treatment

iTeos Therapeutics

14/06/2021 12:14

June 14 (Reuters) - GlaxoSmithKline Plc  GSK.L  and iTeos
Therapeutics  ITOS.O  will develop and commercialize iTeos'
potential treatment for patients with cancer, the companies said
on Monday. 
    iTeos will receive a $625 million upfront payment.

 (Reporting by Vishwadha Chander in Bengaluru; Editing by Devika
Syamnath)
 ((Vishwadha.Chander@thomsonreuters.com; Mobile: +91 7506036802;
Twitter:  https://twitter.com/vishwadha;))